New psychopharmacotherapy dilemmas associated with COVID-19 – case report

Jolanta Kucharska-Mazur; Jędrzej Stańczak; Jerzy Samochowiec

eISSN: 2449-9315
ISSN: 1234-8279

Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii

Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Without publication fees

Open access

2/2020
vol. 36

Send email

Copy url:

Case report

New psychopharmacotherapy dilemmas associated with COVID-19 – case report

Jolanta Kucharska-Mazur

¹

,

Jędrzej Stańczak

¹

,

Jerzy Samochowiec

¹

Department of Psychiatry, Pomeranian Medical University in Szczecin

Farmakoterapia w Psychiatrii i Neurologii 2020, 36 (2), 149–153

Online publish date: 2021/12/06

Article file

- 06R_IPiN_FARM_2020-2C.pdf [0.11 MB]

Get citation

1. Arechin, ChPL, http://www.urpl.gov.pl/sites/default/files/Are chin%20Charakterystyka%20Produktu%20Leczniczego.pdf.

2. Detailed recommendations for interactions with experimen tal COVID-19 therapies. https://www.covid19-druginterac tions.org/, University of Liverpool.

3. Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 as sociated pneumonia in clinical studies. Biosci Trends. 2020 Mar 16; 14(1): 72–73. Doi: 10.5582/bst.2020.01047. Epub 2020 Feb 19.

4. Saleh M, Gabriels J, Chang D, Kim BS, Mansoor A, Mahmood E, Makker P, Ismail H, Goldner B, Willner J, Beldner S, Mitra R, John R, Chinitz J, Skipitaris N, Mountantonakis S, Epstein LM. The Effect of Chloroquine, Hydroxychloroquine and Azithromycin on the Corrected QT Interval in Patients with SARS-CoV-2 Infection. Circ Arrhythm Electrophysiol. 2020 Apr 29. doi: 10.1161/CIRCEP.120.008662.

5. Touret F, Lamballerie X. Of chloroquine and COVID-19, Antiviral Res. 2020 May; 177: 104762. Doi: 10.1016/j.anti viral.2020.104762.

6. Uvais NA. The Risks of Prescribing Hyodroxychloroquine in COVID-19-Infected Patients With Schizophrenia. Prim Care Companion CNS Disord. 2020 Apr 30;22(3). pii: 20com02635. Doi: 10.4088/PCC.20com02635

New psychopharmacotherapy dilemmas associated with COVID-19 – case report

Jolanta Kucharska-Mazur 1 , Jędrzej Stańczak 1 , Jerzy Samochowiec 1

Jolanta Kucharska-Mazur

¹

,

Jędrzej Stańczak

¹

,

Jerzy Samochowiec

¹